NYSE - Nasdaq Real Time Price USD
Edwards Lifesciences Corporation (EW)
75.50
+0.70
+(0.94%)
At close: May 13 at 4:00:02 PM EDT
75.22
-0.28
(-0.37%)
Pre-Market: 8:09:33 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 265,875 | 40 |
| Sales | 122,503 | 23 |
| Net Shares Purchased (Sold) | 143,372 | 63 |
| Total Insider Shares Held | 5.4M | -- |
| % Net Shares Purchased (Sold) | 2.70% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LAVIOLETTE PAUL A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2025 |
| FEINBERG DAVID T Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2025 |
| GALLAHUE KIERAN T. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2025 |
| LORANGER STEVEN R Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2025 |
| STONE HEISZ LESLIE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2025 |
| VALERIANI NICHOLAS J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2025 |
| ULLEM SCOTT B Chief Financial Officer | Sale at price 74.40 per share. | Direct | 837,035 | May 9, 2025 |
| ULLEM SCOTT B Chief Financial Officer | Conversion of Exercise of derivative security at price 45.28 per share. | Direct | 509,363 | May 9, 2025 |
| SEQUEIRA RAMONA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2025 |
| LIPPIS DANIEL J Officer | Sale at price 74.42 per share. | Direct | 24,560 | May 9, 2025 |
| LIPPIS DANIEL J Officer | Conversion of Exercise of derivative security at price 45.28 per share. | Direct | 14,941 | May 9, 2025 |
| DAVIS LESLIE C. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2025 |
| BOBO DONALD E JR Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 8, 2025 |
| WOOD LARRY L Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 8, 2025 |
| ULLEM SCOTT B Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 8, 2025 |
| ZOVIGHIAN BERNARD J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 8, 2025 |
| ZOVIGHIAN BERNARD J Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | May 8, 2025 |
| CHOPRA DAVEEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 8, 2025 |
| MARKOWITZ WAYNE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 8, 2025 |
| LIPPIS DANIEL J Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 8, 2025 |
| DAHL ANDREW M Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 8, 2025 |
| BRULS ANNETTE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 8, 2025 |
| MARKOWITZ WAYNE Officer | Sale at price 75.08 per share. | Direct | 20,121 | May 7, 2025 |
| ZOVIGHIAN BERNARD J Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | May 6, 2025 |
| ZOVIGHIAN BERNARD J Chief Executive Officer | Sale at price 74.91 per share. | Direct | 447,977 | May 5, 2025 |
| ZOVIGHIAN BERNARD J Chief Executive Officer | Conversion of Exercise of derivative security at price 45.28 per share. | Direct | 337,855 | May 5, 2025 |
| BOBO DONALD E JR Officer | Sale at price 69.81 per share. | Direct | 663,196 | Apr 14, 2025 |
| BOBO DONALD E JR Officer | Conversion of Exercise of derivative security at price 45.28 per share. | Direct | 430,129 | Apr 14, 2025 |
| LIPPIS DANIEL J Officer | Sale at price 70.61 per share. | Direct | 21,183 | Apr 8, 2025 |
| LIPPIS DANIEL J Officer | Conversion of Exercise of derivative security at price 45.28 per share. | Direct | 13,583 | Apr 8, 2025 |
| ULLEM SCOTT B Chief Financial Officer | Sale at price 70.87 per share. | Direct | 797,267 | Mar 26, 2025 |
| ULLEM SCOTT B Chief Financial Officer | Conversion of Exercise of derivative security at price 45.28 per share. | Direct | 509,363 | Mar 26, 2025 |
| BOBO DONALD E JR Officer | Sale at price 67.96 per share. | Direct | 645,624 | Mar 13, 2025 |
| BOBO DONALD E JR Officer | Conversion of Exercise of derivative security at price 45.28 per share. | Direct | 430,129 | Mar 13, 2025 |
| ZOVIGHIAN BERNARD J Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Mar 10, 2025 |
| ZOVIGHIAN BERNARD J Chief Executive Officer | Sale at price 69.51 per share. | Direct | 428,448 | Mar 10, 2025 |
| ZOVIGHIAN BERNARD J Chief Executive Officer | Conversion of Exercise of derivative security at price 45.28 per share. | Direct | 337,900 | Mar 10, 2025 |
| LIPPIS DANIEL J Officer | Sale at price 69.48 per share. | Direct | 27,792 | Mar 10, 2025 |
| LIPPIS DANIEL J Officer | Conversion of Exercise of derivative security at price 45.28 per share. | Direct | 18,111 | Mar 10, 2025 |
| ULLEM SCOTT B Chief Financial Officer | Sale at price 70.52 - 71.38 per share. | Direct | 796,327 | Feb 28, 2025 |
| ULLEM SCOTT B Chief Financial Officer | Conversion of Exercise of derivative security at price 45.28 per share. | Direct | 509,363 | Feb 28, 2025 |
| LORANGER STEVEN R Director | Sale at price 76.42 per share. | Direct | 438,576 | Feb 14, 2025 |
| LORANGER STEVEN R Director | Conversion of Exercise of derivative security at price 45.32 per share. | Direct | 260,073 | Feb 14, 2025 |
| BOBO DONALD E JR Officer | Sale at price 75.74 - 76.26 per share. | Direct | 492,363 | Feb 13, 2025 |
| BOBO DONALD E JR Officer | Conversion of Exercise of derivative security at price 45.28 per share. | Direct | 294,299 | Feb 13, 2025 |
| STONE HEISZ LESLIE Director | Sale at price 75.86 per share. | Direct | 435,371 | Feb 13, 2025 |
| STONE HEISZ LESLIE Director | Conversion of Exercise of derivative security at price 45.32 per share. | Direct | 260,073 | Feb 13, 2025 |
| ULLEM SCOTT B Chief Financial Officer | Sale at price 75.76 per share. | Direct | 852,272 | Feb 13, 2025 |
| ULLEM SCOTT B Chief Financial Officer | Conversion of Exercise of derivative security at price 45.28 per share. | Direct | 509,363 | Feb 13, 2025 |
| LIPPIS DANIEL J Officer | Sale at price 76.34 per share. | Direct | 38,170 | Feb 13, 2025 |
Related Tickers
BSX Boston Scientific Corporation
102.95
+0.08%
MDT Medtronic plc
85.11
-0.82%
DXCM DexCom, Inc.
84.11
-1.11%
ZBH Zimmer Biomet Holdings, Inc.
97.49
-0.74%
SYK Stryker Corporation
387.53
-0.14%
MASI Masimo Corporation
161.56
-1.22%
ABT Abbott Laboratories
129.05
-2.23%
PODD Insulet Corporation
314.46
-0.70%
INSP Inspire Medical Systems, Inc.
159.76
+2.12%
BIO Bio-Rad Laboratories, Inc.
253.15
-1.38%